Maurizio Bonati is professor of public health at the Istituto di Ricerche Farmacologiche Mario Negri IRCSS in Milan, Italy.
Maurizio Bonati
Professor
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
From this contributor
Clinicians should consider off-label treatments for autism
Clinicians need a more consistent and evidence-based approach to prescribing antipsychotics to children and adolescents with autism.
Clinicians should consider off-label treatments for autism
Explore more from The Transmitter
Neuroscience needs single-synapse studies
Studying individual synapses has the potential to help neuroscientists develop new theories, better understand brain disorders and reevaluate 70 years of work on synaptic transmission plasticity.
Neuroscience needs single-synapse studies
Studying individual synapses has the potential to help neuroscientists develop new theories, better understand brain disorders and reevaluate 70 years of work on synaptic transmission plasticity.
New insights on sex bias in autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 February.
New insights on sex bias in autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 February.
Neuroscience has a species problem
If our field is serious about building general principles of brain function, cross-species dialogue must become a core organizing principle rather than an afterthought.
Neuroscience has a species problem
If our field is serious about building general principles of brain function, cross-species dialogue must become a core organizing principle rather than an afterthought.